About GREFFEX INC
Greffex Inc. is a genetic engineering company specializing in the development of next-generation gene transfer vectors for gene therapy and vaccines. The company's platform is designed to outperform existing vaccines by offering higher effectiveness, longer protection, and lower costs.
Development of next-generation gene transfer vectors for gene therapy and vaccinesCreation of fully-deleted, helper-independent vectors for vaccine developmentDesign and production of vaccines in 3-4 weeks using target disease genetic sequencesPipeline of over 10 vaccine candidates including H5N1, Universal Flu, Anthrax, Ebola, Dengue, Zika, and Lyme’s diseaseManufacturing of vaccines using a standardized, highly efficient process
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| TO MAKE AN AWARD UNDER HHS-NIH-NIAID-BAA2018 | Department of Health and Human Services | $11.2M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to GREFFEX INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.